Metastatic colorectal cancer: role of target therapies and future perspectives.

Metastatic colorectal cancer: role of target therapies and future perspectives.

Item
http://www.wikidata.org/entity/Q38759246
Incidence and risk of regorafenib-induced hepatotoxicity.Incidence and risk of hematologic toxicities in cancer patients treated with regorafenib.Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine.Sorting nexin 10 controls mTOR activation through regulating amino-acid metabolism in colorectal cancer.First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis.Novel targeting approaches and signaling pathways of colorectal cancer: An insightIntegration of stereotactic radiotherapy in the treatment of metastatic colorectal cancer patients: a real practice study with long-term outcome and prognostic factors
P2860

Metastatic colorectal cancer: role of target therapies and future perspectives.

Item
http://www.wikidata.org/entity/Q38759246
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Metastatic colorectal cancer: role of target therapies and future perspectives.
@en
type
label
Metastatic colorectal cancer: role of target therapies and future perspectives.
@en
prefLabel
Metastatic colorectal cancer: role of target therapies and future perspectives.
@en
P1433
P1476
P2093
P31
P356
P577
P698
P921
P356
P1433
P1476
Metastatic colorectal cancer: role of target therapies and future perspectives.
@en
P2093
P31
P356
10.2174/1568009617666170209095143
P577
P698
P921